Searchable abstracts of presentations at key conferences in endocrinology

ea0011p357 | Diabetes, metabolism and cardiovascular | ECE2006

Relationship between plasma visfatin levels and the metabolic variables in metabolic syndrome

Sonmez Alper , Dogru Teoman , Tasci Ilker , Yilmaz Ilker , Pinar Murat , Naharci Ilkin , Bingol Necati , Kilic Selim , Demirtas Ayla , Bingol Sezin , Musabak Ugur , Ozgurtas Taner , Erbil Kemal , Erikci Selaha

Objective: Visfatin, a novel adipocytokine, is predominantly expressed in visceral fat and correlated with obesity. The pathophysiologic role of visfatin in metabolic syndrome (MS) is not clear. We aimed to investigate the relationship between plasma visfatin levels and components of MS, and also the effect of therapeutic lifestyle change (TLC) on these parameters.Design and methods: Nineteen patients (5 male, 14 female; mean age 51.0±9.3 years; bod...

ea0011p359 | Diabetes, metabolism and cardiovascular | ECE2006

The effect of fluvastatin on adiponectin and insulin sensitivity

Sonmez Alper , Dogru Teoman , Tasci Ilker , Yilmaz Ilker , Pinar Murat , Naharci Ilkin , Bingol Necati , Kilic Selim , Demirtas Ayla , Bingol Sezin , Musabak Ugur , Ozgurtas Taner , Erbil Kemal , Erikci Selaha

Objective: The pleiotropic functions of statins are crucial in reducing cardiovascular events. There is controversy about their effects on insulin resistance. The aim of this study was to investigate the effect of Fluvastatin treatment on plasma adiponectin and insulin levels in a group of dyslipidemic population who had no confounding factors for insulin resistance such as diabetes or hypertension.Design and methods: Forty nine (27 male, 22 female; mean...

ea0090p648 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Five-year trends of Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with type 2 Diabetes (TEMD-2 study), 2017-2022

Sonmez Alper , Haymana Cem , Demirci İbrahim , Cetinarslan Berrin , Gonen Sait , Murat Akbas Emin , Yenidunya Yalin Gulsah , Avci Ugur , Tasci Ilker , Salman Serpil , Bayram Fahri , Satman Ilhan , Study Group TEMD-2

Objective: Establishing good metabolic control is essential to prevent morbidity and mortality in patients with type 2 diabetes (T2DM). This nationwide survey is performed five years after the first national TEMD study, to search for any improvement in attaining glycemic and metabolic targets in Turkish patients with T2DM.Methods: The nationwide, multicenter survey consecutively enrolled patients who were under follow up for at least a year in tertiary c...

ea0022p327 | Diabetes | ECE2010

Chitotriosidase activity predicts endothelial dysfunction in type 2 diabetes mellitus

Haymana Cem , Sonmez Alper , Tapan Serkan , Safer Umut , Celebi Gurkan , Ozturk Ozlem , Genc Halil , Dogru Teoman , Tasci Ilker , Erdem Gokhan , Taslipinar Abdullah , Aydogdu Aydogan , Yilmaz Mahmut I , Kurt Ismail , Kutlu Mustafa

The enzyme chitotriosidase (ChT) is secreted by activated macrophages and play active role in human immune response. ChT activity is increased in atherosclerosis in association to the extent of the disease. We investigated the relevance of ChT to endothelial functions and insulin resistance in patients with T2DM.Forty newly diagnosed and untreated patients with T2DM (male 17; age: 47.0±6.2 years) and 50 healthy volunteers (male 21; age: 50.2±8....